BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16374685)

  • 1. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.
    Soongswang J; Sangtawesin C; Durongpisitkul K; Laohaprasitiporn D; Nana A; Punlee K; Kangkagate C
    Pediatr Cardiol; 2005; 26(4):361-6. PubMed ID: 16374685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U; Rossi E; Littarru GP; Frustaci A; Lippa S; Oradei A; Aureli V
    Int J Tissue React; 1990; 12(3):173-8. PubMed ID: 2276896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.
    Langsjoen H; Langsjoen P; Langsjoen P; Willis R; Folkers K
    Mol Aspects Med; 1994; 15 Suppl():s165-75. PubMed ID: 7752828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy.
    Sacher HL; Sacher ML; Landau SW; Kersten R; Dooley F; Sacher A; Sacher M; Dietrick K; Ichkhan K
    Am J Ther; 1997; 4(2-3):66-72. PubMed ID: 10423594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy.
    Kocharian A; Shabanian R; Rafiei-Khorgami M; Kiani A; Heidari-Bateni G
    Cardiol Young; 2009 Sep; 19(5):501-6. PubMed ID: 19703336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential usefulness of coenzyme Q10 in the treatment of idiopathic dilated cardiomyopathy in children.
    Elshershari H; Ozer S; Ozkutlu S; Ozme S
    Int J Cardiol; 2003 Mar; 88(1):101-2. PubMed ID: 12659993
    [No Abstract]   [Full Text] [Related]  

  • 7. A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy.
    Chen FL; Chang PS; Lin YC; Lin PT
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30405022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 treatment in serious heart failure.
    Munkholm H; Hansen HH; Rasmussen K
    Biofactors; 1999; 9(2-4):285-9. PubMed ID: 10416042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of taurine in chronic congestive heart failure and its prospective application.
    Azuma J; Sawamura A; Awata N
    Jpn Circ J; 1992 Jan; 56(1):95-9. PubMed ID: 1538580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardiomyopathy: assessment by iodine-123 labelled 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid myocardial single-photon emission tomography.
    Kim Y; Sawada Y; Fujiwara G; Chiba H; Nishimura T
    Eur J Nucl Med; 1997 Jun; 24(6):629-34. PubMed ID: 9169569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Klin Wochenschr; 1988 Jul; 66(13):583-90. PubMed ID: 3062263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy.
    Permanetter B; Rössy W; Klein G; Weingartner F; Seidl KF; Blömer H
    Eur Heart J; 1992 Nov; 13(11):1528-33. PubMed ID: 1464342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
    Davini A; Cellerini F; Topi PL
    Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
    Folkers K; Langsjoen P; Langsjoen PH
    Biochem Biophys Res Commun; 1992 Jan; 182(1):247-53. PubMed ID: 1731784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Int J Tissue React; 1990; 12(3):163-8. PubMed ID: 2276894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.
    Salles JE; Moisés VA; Almeida DR; Chacra AR; Moisés RS
    Diabetes Res Clin Pract; 2006 Apr; 72(1):100-3. PubMed ID: 16253379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effects of coenzyme Q10 on dilated cardiomyopathy: assessment by 123I-BMIPP myocardial single photon emission computed tomography (SPECT): a multicenter trial in Osaka University Medical School Group].
    Nishimura T; Hori M
    Kaku Igaku; 1996 Jan; 33(1):27-32. PubMed ID: 8819712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine in children with idiopathic dilated cardiomyopathy.
    Kothari SS; Sharma M
    Indian Heart J; 1998; 50(1):59-61. PubMed ID: 9583289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review.
    Azevedo VM; Santos MA; Albanesi Filho FM; Castier MB; Tura BR; Amino JG
    Cardiol Young; 2007 Apr; 17(2):175-84. PubMed ID: 17244382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.